Novel chemotactic For-Met-Leu-Phe-OMe (fMLF-OMe) analogues based on met residue replacement by 4-amino-proline scaffold: synthesis and bioactivity. 2009

Domenica Torino, and Adriano Mollica, and Francesco Pinnen, and Federica Feliciani, and Susanna Spisani, and Gino Lucente
Dipartimento di Chimica e Tecnologie del Farmaco and Istituto di Chimica Biomolecolare, CNR Sezione di Roma, "Sapienza", Università di Roma, P.le A.Moro, 00185 Roma, Italy.

cis-(2S,4S) 4-amino-proline (cAmp) and trans-(2S,4R) 4-amino-proline (tAmp) residues, bearing N-For or N-Boc substituents at the two amino groups, have been incorporated into the potent chemotactic agent fMLF-OMe in place of the N-terminal native (S)-methionine to give the analogues 17a-19a and 17b-19b. The new ligands have been examined for their activity (chemotaxis, superoxide anion production and lysozyme release) on human neutrophils as agonists and antagonists. Compounds 19a and 19b, bearing two N-For groups at the proline scaffold, are active and selective chemoattractants. The ligand 18b, containing N-For at the 4-amino group of the N-Boc-tAmp residue, exhibits significant chemotactic antagonism. The influence of the different substitution at the N-terminal position of the new analogues is discussed.

UI MeSH Term Description Entries
D008024 Ligands A molecule that binds to another molecule, used especially to refer to a small molecule that binds specifically to a larger molecule, e.g., an antigen binding to an antibody, a hormone or neurotransmitter binding to a receptor, or a substrate or allosteric effector binding to an enzyme. Ligands are also molecules that donate or accept a pair of electrons to form a coordinate covalent bond with the central metal atom of a coordination complex. (From Dorland, 27th ed) Ligand
D009113 Muramidase A basic enzyme that is present in saliva, tears, egg white, and many animal fluids. It functions as an antibacterial agent. The enzyme catalyzes the hydrolysis of 1,4-beta-linkages between N-acetylmuramic acid and N-acetyl-D-glucosamine residues in peptidoglycan and between N-acetyl-D-glucosamine residues in chitodextrin. EC 3.2.1.17. Lysozyme,Leftose,N-Acetylmuramide Glycanhydrolase,Glycanhydrolase, N-Acetylmuramide,N Acetylmuramide Glycanhydrolase
D009240 N-Formylmethionine Leucyl-Phenylalanine A formylated tripeptide originally isolated from bacterial filtrates that is positively chemotactic to polymorphonuclear leucocytes, and causes them to release lysosomal enzymes and become metabolically activated. F-Met-Leu-Phe,N-Formyl-Methionyl-Leucyl-Phenylalanine,Formylmet-Leu-Phe,Formylmethionyl Peptide,Formylmethionyl-Leucyl-Phenylalanine,Formylmethionylleucylphenylalanine,N-Formylated Peptide,N-formylmethionyl-leucyl-phenylalanine,fMet-Leu-Phe,F Met Leu Phe,Formylmet Leu Phe,Formylmethionyl Leucyl Phenylalanine,Leucyl-Phenylalanine, N-Formylmethionine,N Formyl Methionyl Leucyl Phenylalanine,N Formylated Peptide,N Formylmethionine Leucyl Phenylalanine,N formylmethionyl leucyl phenylalanine,Peptide, Formylmethionyl,Peptide, N-Formylated,fMet Leu Phe
D009504 Neutrophils Granular leukocytes having a nucleus with three to five lobes connected by slender threads of chromatin, and cytoplasm containing fine inconspicuous granules and stainable by neutral dyes. LE Cells,Leukocytes, Polymorphonuclear,Polymorphonuclear Leukocytes,Polymorphonuclear Neutrophils,Neutrophil Band Cells,Band Cell, Neutrophil,Cell, LE,LE Cell,Leukocyte, Polymorphonuclear,Neutrophil,Neutrophil Band Cell,Neutrophil, Polymorphonuclear,Polymorphonuclear Leukocyte,Polymorphonuclear Neutrophil
D011392 Proline A non-essential amino acid that is synthesized from GLUTAMIC ACID. It is an essential component of COLLAGEN and is important for proper functioning of joints and tendons. L-Proline,L Proline
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D002633 Chemotaxis The movement of cells or organisms toward or away from a substance in response to its concentration gradient. Haptotaxis
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000595 Amino Acid Sequence The order of amino acids as they occur in a polypeptide chain. This is referred to as the primary structure of proteins. It is of fundamental importance in determining PROTEIN CONFORMATION. Protein Structure, Primary,Amino Acid Sequences,Sequence, Amino Acid,Sequences, Amino Acid,Primary Protein Structure,Primary Protein Structures,Protein Structures, Primary,Structure, Primary Protein,Structures, Primary Protein
D013481 Superoxides Highly reactive compounds produced when oxygen is reduced by a single electron. In biological systems, they may be generated during the normal catalytic function of a number of enzymes and during the oxidation of hemoglobin to METHEMOGLOBIN. In living organisms, SUPEROXIDE DISMUTASE protects the cell from the deleterious effects of superoxides. Superoxide Radical,Superoxide,Superoxide Anion

Related Publications

Domenica Torino, and Adriano Mollica, and Francesco Pinnen, and Federica Feliciani, and Susanna Spisani, and Gino Lucente
December 1995, Amino acids,
Domenica Torino, and Adriano Mollica, and Francesco Pinnen, and Federica Feliciani, and Susanna Spisani, and Gino Lucente
April 2006, Bioorganic & medicinal chemistry,
Domenica Torino, and Adriano Mollica, and Francesco Pinnen, and Federica Feliciani, and Susanna Spisani, and Gino Lucente
July 2009, Amino acids,
Domenica Torino, and Adriano Mollica, and Francesco Pinnen, and Federica Feliciani, and Susanna Spisani, and Gino Lucente
June 2012, Journal of peptide science : an official publication of the European Peptide Society,
Domenica Torino, and Adriano Mollica, and Francesco Pinnen, and Federica Feliciani, and Susanna Spisani, and Gino Lucente
September 2007, Amino acids,
Domenica Torino, and Adriano Mollica, and Francesco Pinnen, and Federica Feliciani, and Susanna Spisani, and Gino Lucente
September 1995, Archiv der Pharmazie,
Domenica Torino, and Adriano Mollica, and Francesco Pinnen, and Federica Feliciani, and Susanna Spisani, and Gino Lucente
December 1991, International journal of peptide and protein research,
Domenica Torino, and Adriano Mollica, and Francesco Pinnen, and Federica Feliciani, and Susanna Spisani, and Gino Lucente
August 2004, Journal of peptide science : an official publication of the European Peptide Society,
Domenica Torino, and Adriano Mollica, and Francesco Pinnen, and Federica Feliciani, and Susanna Spisani, and Gino Lucente
December 2004, Farmaco (Societa chimica italiana : 1989),
Domenica Torino, and Adriano Mollica, and Francesco Pinnen, and Federica Feliciani, and Susanna Spisani, and Gino Lucente
April 2006, Bioorganic & medicinal chemistry,
Copied contents to your clipboard!